Jump to content

  • Set Your Location
  • Sign in or Enroll
Set Your LocationPalo Alto Medical Foundation
  • Sign in or Enroll
    • Open I want to choose my medical group or hospital
    • Clear my location
Change Location
Sutter Health
  • Book Appointment
  • Find Doctors
  • Find Locations
  • Treatments & Services
    • Book Appointment
    • Find Doctors
    • Find Locations
    • Treatments & Services
    • COVID-19 Resources
    • Pay a Bill
    • Symptom Checker
    • Get Care Today
    • Health & Wellness
    • Classes & Events
    • Research & Clinical Trials
    • For Patients
    • About Sutter Health
    • Giving
    • Volunteering
    • Careers
    • News
    • For Medical Professionals
    • Other Business Services
Close Search
  • Home
  • PAMF
  • Research
  • Search Results
Content

Research Search Results

You are viewing results from Research and Clinical Trials.

5results found for:

Result Type
clinical trial
Health Topic
ms (multiple sclerosis)
  • Alpha
  • Reverse Alpha
    • East Bay  (3)
    • Palo Alto/Santa Cruz  (1)

    A phase III multicenter, randomized, double-blind, double-dummy, parallel-group study to evaluate the efficacy and safety of fenebrutinib compared with ocrelizumab in adult patients with PPMS

    Result Type
    clinical trial

    Multiple sclerosis study to evaluate effectiveness and safety of fenebrutinib

    Status: Active, Not Recruiting

    A Phase III Multicenter, Randomized, Double-Blind, Double-Dummy, Parallel-Group Study To Evaluate The Efficacy And Safety Of Fenebrutinib Compared With Ocrelizumab In Adult Patients With Primary Progr

    Result Type
    clinical trial

    A PHASE III MULTICENTER, RANDOMIZED, DOUBLE BLIND, DOUBLE DUMMY, PARALLEL GROUP STUDY TO EVALUATE THE EFFICACY AND SAFETY OF FENEBRUTINIB IN ADULTS WITH PROGRES

    Status: Active, Not Recruiting

    ARTIOS

    Result Type
    clinical trial

    An Open-label Study Evaluating Ofatumumab Treatment Effectiveness and PROs in Subjects With RMS Transitioning From Dimethyl Fumarate or Fingolimod to Ofatumumab

    Status: Completed

    M14

    Result Type
    clinical trial

    A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Progressive Forms of Multiple Sclerosis

    Status: Completed

    M18

    Result Type
    clinical trial

    A Study to Assess the Safety and Efficacy of Elezanumab When Added to Standard of Care in Relapsing Forms of Multiple Sclerosis

    Status: Completed

    The Sutter Health Network of Care
    Expertise to fit your needs
    Primary Care

    Check-ups, screenings and sick visits for adults and children.

    Specialty Care

    Expertise and advanced technologies in all areas of medicine.

    Emergency Care

    For serious accidents, injuries and conditions that require immediate medical care.

    Urgent Care

    After-hours, weekend and holiday services.

    Walk-In Care

    Convenient walk-in care clinics for your non-urgent health needs.

    • Contact Us
    • Find Doctors
    • Find Locations
    • Book Appointment
    • Request Medical Records
    • Donate Now
    Sign in to My Health Online

    Billing and Insurance

    • Pay a Bill
    • Accepted Health Plans
    • Estimate Costs
    • Medicare Advantage

    About Sutter

    • About Our Network
    • Community Benefit
    • Annual Report
    • News and Media

    Our Team

    • For Employees
    • For Medical Professionals
    • For Vendors
    • For Volunteers

    Careers

    • Jobs at Sutter
    • Physician Jobs
    • Graduate Medical Education

    Copyright © 2023 Sutter Health. All rights reserved. Sutter Health is a registered trademark of Sutter Health ®, Reg. U.S. Patent & Trademark office.

    • ADA Accessibility
    • Privacy
    • Do Not Sell My Personal Information
    • LinkedIn Opens new window
    • YouTube Opens new window
    • Facebook Opens new window
    • Twitter Opens new window
    • Instagram Opens new window
    • Glassdoor Opens new window

    Cookie Policy

    We use cookies to give you the best possible user experience. By continuing to use the site, you agree to the use of cookies. Privacy Policy Cookie Preferences

    Privacy Policy Cookie Preferences